Prostaglandin I2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice.
Kumei S, Yuhki KI, Kojima F, Kashiwagi H, Imamichi Y, Okumura T, Narumiya S, Ushikubi F.
Kumei S, et al. Among authors: kojima f.
FASEB J. 2018 May;32(5):2354-2365. doi: 10.1096/fj.201700590R. Epub 2017 Dec 15.
FASEB J. 2018.
PMID: 29247122
We suggest that the PGI(2)-IP system is an attractive therapeutic target for treating patients with NASH.-Kumei, S., Yuhki, K.-I., Kojima, F., Kashiwagi, H., Imamichi, Y., Okumura, T., Narumiya, S., Ushikubi, F. ...
We suggest that the PGI(2)-IP system is an attractive therapeutic target for treating patients with NASH.-Kumei, S., Yuhki, K.-I., Kojima …